Terms: = Breast cancer AND TRIM33, RFG7, 51592, ENSG00000197323, Q9UPN9, TF1G, FLJ32925, TIF1G, PTC7, TIFGAMMA, TIF1GAMMA AND Prognosis
3 results:
1. Mapping Bromodomains in breast cancer and association with clinical outcome.
Pérez-Pena J; Páez R; Nieto-Jiménez C; Sánchez VC; Galan-Moya EM; Pandiella A; Győrffy B; Ocana A
Sci Rep; 2019 Apr; 9(1):5734. PubMed ID: 30952871
[TBL] [Abstract] [Full Text] [Related]
2. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
Kubeček O; Soukup T; Paulík A; Kopecký J
BMC Cancer; 2016 Aug; 16(1):684. PubMed ID: 27561848
[TBL] [Abstract] [Full Text] [Related]
3. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract] [Full Text] [Related]